Therapeutic compounds and compositions for treating social disorders and substance use disorders
申请人:Kinoxis Therapeutics Pty Ltd
公开号:US11033555B2
公开(公告)日:2021-06-15
Disclosed herein are compounds, compositions and methods for the treatment of neurological, psychiatric disorders which are characterised by a fundamental disruption of social behaviour, and substance use disorders. In particular, disclosed herein are compounds of Formula (I), or salts or prodrugs thereof. Methods of treating or preventing neurological, psychiatric disorders and substance use disorders, using compounds of Formula (I), or salts and prodrugs are also disclosed.
本文公开了用于治疗以社会行为的根本性破坏为特征的神经和精神障碍以及药物使用障碍的化合物、组合物和方法。特别是,本文公开了式(I)化合物或其盐类或原药。此外,还公开了使用式(I)化合物或其盐及原药治疗或预防神经、精神障碍和药物使用障碍的方法。